| GIIRX | VFWPX | GIIRX / VFWPX | |
| Total Expense Ratio | 1.04 | 0.03 | 3,467% |
| Annual Report Gross Expense Ratio | 1.07 | 0.03 | 3,567% |
| Fund Existence | 19 years | 15 years | - |
| Gain YTD | 3.475 | 4.210 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 861M | 78.2B | 1% |
| Annual Yield % from dividends | 3.39 | 3.10 | 109% |
| Returns for 1 year | 29.96 | 34.53 | 87% |
| Returns for 3 years | 46.50 | 46.09 | 101% |
| Returns for 5 years | 43.01 | 32.70 | 132% |
| Returns for 10 years | 100.54 | 110.03 | 91% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VGVT | 76.40 | 0.12 | +0.15% |
| Vanguard Government Securities Actv ETF | |||
| ECML | 34.73 | N/A | N/A |
| Euclidean Fundamental Value ETF | |||
| ULST | 40.56 | -0.01 | -0.01% |
| State Street® Ultra Short Term Bond ETF | |||
| JULH | 24.95 | N/A | -0.02% |
| Innovator Premium Income 20 Bar ETF -Jul | |||
| XBI | 124.35 | -2.47 | -1.95% |
| State Street® SPDR® S&P® Biotech ETF | |||